Mucinex dm and Visual impairment - a phase IV clinical study of FDA data

Summary:

Visual impairment is reported as a side effect among people who take Mucinex dm (dextromethorphan hydrobromide; guaifenesin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Claritin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Visual impairment when taking Mucinex dm. It is created by eHealthMe based on reports of 2,899 people who have side effects when taking Mucinex dm from the FDA, and is updated regularly.

What is Mucinex dm?

Mucinex dm has active ingredients of dextromethorphan hydrobromide; guaifenesin. It is often used in cough. eHealthMe is studying from 3,604 Mucinex dm users. Check the latest studies of Mucinex dm.

What is Visual impairment?

Visual impairment is found to be associated with 2,257 drugs and 2,336 conditions by eHealthMe. Check the latest studies of Visual impairment.

On Jul, 11, 2026

2,899 people reported to have side effects when taking Mucinex dm.
Among them, 13 people (0.45%) have Visual impairment.

Could Mucinex dm cause Visual impairment?

Among these 13 people:

How long have people been on Mucinex dm when they have Visual impairment? *

What is the gender of people who have Visual impairment when taking Mucinex dm? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Visual impairment when taking Mucinex dm? *

What are other drugs people take besides Mucinex dm? *

What are other side effects people have besides Visual impairment? *

Gastritis (inflammation of stomach): 3 people, 23.08%
Headache (pain in head): 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 23.08%
Dyspnea (difficult or laboured breathing): 3 people, 23.08%
Eye Irritation: 2 people, 15.38%
Dizziness: 2 people, 15.38%
Drug Ineffective: 2 people, 15.38%
Dry Eyes (lack of adequate tears): 2 people, 15.38%
Loss Of Consciousness: 2 people, 15.38%

What are the existing conditions these people have? *

Nasopharyngitis (inflammation of the nasopharynx): 2 people, 15.38%
Insomnia (sleeplessness): 2 people, 15.38%
Type 2 Diabetes: 2 people, 15.38%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%
Back Pain: 1 person, 7.69%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%
Connective Tissue Disorder (any disease that has the connective tissues of the body): 1 person, 7.69%
Constipation: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mucinex dm and have Visual impairment?

- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mucinex dm:

Mucinex dm (3,604 reports)

Visual impairment treatments and more:

Visual impairment (128,338 reports)

How severe was Visual impairment and when was it recovered:

Visual impairment in Mucinex dm

Expand to all the drugs that have ingredients of dextromethorphan hydrobromide; guaifenesin:

Visual impairment and drugs with ingredients of dextromethorphan hydrobromide; guaifenesin (27 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mucinex dm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual impairment:

Visual impairment (2,257 drugs)

Browse all the conditions that are associated with Visual impairment:

Visual impairment (2,336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dextromethorphan hydrobromide; guaifenesin (the active ingredients of Mucinex dm) and Mucinex dm (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.